e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Biology in thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled microsatellite analysis of 3p predicts poor survival in non small cell lung cancer
G. E. Carpagnano, A. Spanevello, F. Carpagnano, G. P. Palladino, M. G. Cagnazzo, M. P. Foschino Barbaro (Foggia, Bari, Italy)
Source:
Annual Congress 2008 - Biology in thoracic tumours
Session:
Biology in thoracic tumours
Session type:
Oral Presentation
Number:
1340
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. E. Carpagnano, A. Spanevello, F. Carpagnano, G. P. Palladino, M. G. Cagnazzo, M. P. Foschino Barbaro (Foggia, Bari, Italy). Exhaled microsatellite analysis of 3p predicts poor survival in non small cell lung cancer. Eur Respir J 2008; 32: Suppl. 52, 1340
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
3p microsatellite evaluation in NSCLC exhaled breath condensate: validation study
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
Overall survival analysis and characterization of an EGFR mutated non small cell lung cancer (NSCLC) population
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Tumor size and inflammatory cytokines in exhaled breath condensate in patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002
Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
The analysis of CHEK2 gene mutation in small cell lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011
Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Non-random chromosomal breakpoints and genetic predisposition to nonsmall cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 17s
Year: 2001
Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival.
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Exhaled aldehydes as markers of disease in lung cancer patients
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study.
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Characteristics and prognostic relevance of
p
53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept